Biodesix Inc (BDSX)
1.57
+0.01
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Biodesix Shareholders Equity (Quarterly): -5.502M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.502M |
| December 31, 2023 | 4.58M |
| September 30, 2023 | -1.446M |
| June 30, 2023 | -6.993M |
| March 31, 2023 | 4.55M |
| December 31, 2022 | 20.61M |
| September 30, 2022 | -2.903M |
| June 30, 2022 | 7.671M |
| March 31, 2022 | 7.781M |
| Date | Value |
|---|---|
| December 31, 2021 | 19.73M |
| September 30, 2021 | 16.03M |
| June 30, 2021 | 25.77M |
| March 31, 2021 | 36.43M |
| December 31, 2020 | 41.17M |
| September 30, 2020 | -255.18M |
| June 30, 2020 | -20.89M |
| December 31, 2019 | -225.14M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-255.18M
Minimum
Sep 2020
41.17M
Maximum
Dec 2020
-19.63M
Average
4.58M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Fonar Corp | 165.76M |
| XWELL Inc | 13.00M |
| ProPhase Labs Inc | 44.87M |
| Applied DNA Sciences Inc | -0.0481M |
| Veracyte Inc | 1.119B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.20M |
| Total Liabilities (Quarterly) | 92.70M |
| Debt to Equity Ratio | -6.462 |
| Current Ratio | 0.9119 |
| Net Debt Paydown Yield | -1.51% |